Medicxi Fund V

About Medicxi Fund V

Medicxi Fund V is a venture capital firm based in United Kingdom, focusing on Seed stage investments. The fund actively supports founders building innovative solutions in Biotech, Therapeutics, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionUnited Kingdom

Funding StageSeed

Industry Focus

Biotech

Therapeutics

Investor Signals Profile

active

Sweet Spot

Clinical-stage biotech founders targeting large pharma exits

biotech

pharma

life sciences

drug development

oncology

Bullish Signals

€500M Fund V announcedexternal

Sanofi acquired portfolio co $1.6Bexternal

Lilly acquiring portfolio co Centessaexternal

GSK acquiring portfolio co RAPTexternal

FDA IND clearance for portfolio coexternal

3 pharma exits in quick successionexternal

Dual-paratopic antibody IND clearedexternal

Contrarian Signals

Biotech-only, narrow sector focusexternal

Large fund — selective deal paceexternal

Founder Do's

Focus on clinical-stage assets

Show clear FDA/regulatory pathway

Target large pharma as acquirer

Vaccines & immunology welcome

First-in-class mechanisms valued

Founder Don'ts

Avoid non-pharma/biotech sectors

Don't pitch pre-clinical without strong data

Skip if no exit-to-pharma strategy

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€500M

Saves0

Website